Alpha 2.0
Login Register
» Articles » PMID: 2652578

Early Experience with Anti-Tac in Clinical Renal Transplantation

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1989 Feb 1
PMID 2652578
Citations 9
Authors
R L Kirkman
M E Shapiro
C B Carpenter
E L Milford
E L Ramos
N L Tilney
T A Waldmann
C E Zimmerman
T B Strom
Affiliations
Soon will be listed here.
Citing Articles

Interleukin 2 receptor antagonists for kidney transplant recipients.

Webster A, Ruster L, McGee R, Matheson S, Higgins G, Willis N Cochrane Database Syst Rev. 2010; (1):CD003897.

PMID: 20091551 PMC: 7154335. DOI: 10.1002/14651858.CD003897.pub3.

Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: a 25-year personal odyssey.

Waldmann T J Clin Immunol. 2007; 27(1):1-18.

PMID: 17216565 DOI: 10.1007/s10875-006-9060-0.

A humanized antibody that binds to the interleukin 2 receptor.

Queen C, SCHNEIDER W, Selick H, Payne P, Landolfi N, DUNCAN J Proc Natl Acad Sci U S A. 1989; 86(24):10029-33.

PMID: 2513570 PMC: 298637. DOI: 10.1073/pnas.86.24.10029.

Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.

Tendler C, Greenberg S, Blattner W, Manns A, Murphy E, Fleisher T Proc Natl Acad Sci U S A. 1990; 87(13):5218-22.

PMID: 2367534 PMC: 54293. DOI: 10.1073/pnas.87.13.5218.

Transplantation.

Starzl T, Fung J JAMA. 1990; 263(19):2686-7.

PMID: 2329677 PMC: 2962591.